GLP-1s 7X More Likely to Keep the Weight Off? The New Data Is Stunning
Christopher Durham takes a deep look at one of the biggest questions facing people using GLP-1 medications to treat the disease of obesity: what happens after the weight loss? In this episode of The Downsized, Christopher breaks down two major new obesity maintenance studies presented at the European Congress on Obesity and simultaneously published in The Lancet and Nature Medicine. The research explores what happens when patients stay on full-dose tirzepatide, reduce their dose, switch to an oral GLP-1 like Foundayo (orforglipron), or stop treatment entirely after significant weight loss. Christopher explains the real-world implications of the SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN trials, including: Why patients staying on full-dose tirzepatide were 7 times more likely to maintain their weight loss What happened to patients who lowered their dose to 5mg How much weight placebo patients regained after stopping treatment Whether oral GLP-1 medications may become a long-term maintenance option What the studies reveal about obesity biology, food noise, blood sugar, and long-term chronic disease management He also shares his own personal maintenance experience after losing more than 100 pounds and maintaining that loss for over a year using tirzepatide, Zepbound, and Mounjaro. This conversation is designed for people currently using GLP-1 medications, considering treatment, or trying to understand what long-term obesity care may look like in the future. As always, Christopher reminds viewers that he and Laraine are not doctors and this video is not medical advice. Always consult a healthcare professional before making changes to your medication or treatment plan. +++++++++++++++++++++++++++++++++++++++ Start your weight loss journey today! We use Mochi Health: https://app.joinmochi.com/eligibility... Use Laraine’s code for $40 off: QIYGO8. Get your Hume BodyPod today and use our exclusive Downsized code for up to 20% total savings! 👉 Use our Code: THEDOWNSIZED Link to purchase: https://humehealth.com//discount/THED... SHOP OUR AMAZON STORE: https://a.co/d/0gGe1MYq BOOK THE DOWNSIZED AT SEA CRUISE 2026: https://thedownsized.org/downsized-at... DOWNSIZED WEBSITE: https://thedownsized.org/ JOIN CLUB DOWNSIZED: / @thedownsized FOR SPONSORSHIPS, BRAND DEALS & COLLABS: https://thedownsized.org/contact/ +++++++++++++++++++++++++++++++++++++++ 00:00 Life After Weight Loss 01:21 Meet The Downsized 02:35 New Maintenance Studies 04:25 How SURMOUNT Works 05:47 Full Dose Holds Line 07:14 Lower Dose vs Placebo 09:43 Why Regain Happens 12:50 Health Markers Matter 14:35 ATTAIN Oral Switch 15:52 What Foundayo Shows 19:38 Limits and Unknowns 21:49 Practical Takeaways 25:18 Plan Your Maintenance 26:43 Remission Needs Care 27:17 Questions and Wrap Up

Forget Zepbound: 15 New Obesity Drugs Are Coming

GLP-1 Muscle Loss Panic Is Wrong (Here’s the New Research)

Should Everyone Take GLP-1s? (What Changed My Mind)

12 GLP-1 Tips That Helped Me Drop 100 lbs

The New GLP-1 That Helped 1 in 4 People Lose 30% of Their Weight! ENICEPATIDE

'Weight-loss drugs stopped my addiction' | A new hope but at what cost?

$50 Wegovy & Zepbound! The Most Complete Bridge Guide Yet

Tapering Off GLP-1s Like Wegovy & Zepbound: A Clinical Perspective

GLP-1s and Inflammation: The Missing Story! NEW RESEARCH

Are We Using GLP-1 Medications All Wrong? with Dr. Ben Bikman

1 in 4 Have a Tirzepatide Advantage! Downsized News

DO THIS To DOUBLE Your GLP-1 Results to MAXIMIZE Weight Loss

6 SIGNS A 70-Year Old Will Have A LONG LIFE

Why I Take Low-Dose Tirzepatide (& Not Retatrutide)

Why GLP-1s may or may not be for you | Chasing Life

How To Stop The Rebound With Ozempic & Mounjaro

Foundayo’s ADA Data Looks Strong, but There Is a Catch

150: Why Tirzepatide Works Better Than GLP-1 Alone

17 GLP-1 Tips I Wish I Knew Before Starting My Journey

